Sanzyme Biologics is a group company of Sanzyme Private Limited (formerly known as Uni-Sankyo Limited).
Prior to 2001, Sanzyme only produced probiotics and enzymes for its own brands – Sporlac and Sanzyme. After 2005, Sanzyme began work in the ingredients space by developing clinical studies, branding, and regulatory submissions to allow for the sale of its probiotic strains as an ingredient to partner companies.
Today, Sanzyme Biologics works with reputed companies in over 30 countries to meet ingredient requirements in biotech space in the pharmaceutical, food, supplement and animal health segments.
Additional Key Facts
1st to produce Bacillus Coagulans in
India in the year 1972
30+ of PHDs
working at our Campus
# of employees > 200
Head office and facilities located in
Our MilestonesConsistent Innovator in Biologics
Founded as Uni Sankyo,
First Indo-Japanese Joint Venture
Received Technology Transfer from Sankyo,
Japan for Bacillus Coagulans Fermentation,
Manufacturing begins in 1974.
to Parent Company – Sankyo, Japan Commence
Independent marketing begins with
Sales Force of 200 Medical Sales Staff
Enzyme R&D of Aspelase (bread toner)
and proteases is completed, production begins
Production of Probiotic Yeast
Sacchromyces Boulardii begins
Company Inaugurates and Begins
Activity in highly successful aquaculture
probiotic division – ‘Kenko’
Company delinks from Daiichi Sankyo Japan,
and is now an independent entity named
Modern Probiotic Manufacturing factory is
opened, allows access to Export Markets for
Probiotics Including Bacillus Coagulans
Fermentation division demerged from
Pharmaceutical company to form Sanzyme